Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
Kirill Gorshkov, Catherine Z. Chen, Robert Bostwick, et al.
ACS Infectious Diseases (2020) Vol. 7, Iss. 6, pp. 1389-1408
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
Marina Vogel-González, Marc Talló-Parra, Víctor Herrera-Fernández, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 562-562
Open Access | Times Cited: 98
Multi-level inhibition of coronavirus replication by chemical ER stress
Mohammed Samer Shaban, Christin Müller, Christin Mayr‐Buro, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 93
Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection
Komudi Singh, Yunching Chen, Shahin Hassanzadeh, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 85
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
Rong Xiang, Zhengsen Yu, Yang Wang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1591-1623
Open Access | Times Cited: 68
Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity
Kyung‐Hyun Cho, Jae-Ryong Kim, In-Chul Lee, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 209-209
Open Access | Times Cited: 62
A machine learning platform to estimate anti-SARS-CoV-2 activities
Govinda KC, Giovanni Bocci, Srijan Verma, et al.
Nature Machine Intelligence (2021) Vol. 3, Iss. 6, pp. 527-535
Open Access | Times Cited: 56
A guide to the use of bioassays in exploration of natural resources
Jerica Sabotič, Engin Bayram, ‪David Ezra‬‏, et al.
Biotechnology Advances (2024) Vol. 71, pp. 108307-108307
Open Access | Times Cited: 7
Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors
Chaitra Prabhakara, Rashmi Godbole, Parijat Sil, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 7, pp. e1009706-e1009706
Open Access | Times Cited: 53
Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus
Shasha Li, Wenli Liu, Yangzhen Chen, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 1378-1386
Open Access | Times Cited: 50
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19
Xin Hu, Jonathan H. Shrimp, Hui Guo, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 3, pp. 1124-1135
Open Access | Times Cited: 50
Biological activity-based modeling identifies antiviral leads against SARS-CoV-2
Ruili Huang, Miao Xu, Hu Zhu, et al.
Nature Biotechnology (2021) Vol. 39, Iss. 6, pp. 747-753
Open Access | Times Cited: 45
The role of autophagy in controlling SARS‐CoV‐2 infection: An overview on virophagy‐mediated molecular drug targets
Saman Sargazi, Roghayeh Sheervalilou, Mohsen Rokni, et al.
Cell Biology International (2021) Vol. 45, Iss. 8, pp. 1599-1612
Open Access | Times Cited: 42
The Natural Stilbenoid (–)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants
Ian Tietjen, Joel Cassel, Emery T. Register, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 12
Open Access | Times Cited: 41
Functions of Coronavirus Accessory Proteins: Overview of the State of the Art
Puxian Fang, Liurong Fang, Huichang Zhang, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1139-1139
Open Access | Times Cited: 40
Development of human-derived, three-dimensional respiratory epithelial tissue constructs with perfusable microvasculature on a high-throughput microfluidics screening platform
Olive Jung, Yen‐Ting Tung, Esther Sim, et al.
Biofabrication (2022) Vol. 14, Iss. 2, pp. 025012-025012
Open Access | Times Cited: 36
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Kunal Nepali, Ram Lal Sharma, Sachin Sharma, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 28
Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors
Aijia Wu, Kunyu Shi, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115923-115923
Closed Access | Times Cited: 17
Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells
Vanessa F. Merino, Yu Yan, Alvaro A. Ordoñez, et al.
Antiviral Research (2023) Vol. 211, pp. 105550-105550
Open Access | Times Cited: 16
Cnidii fructus and Sophorae Flavescentis Radix polysaccharides inhibit SARS-CoV-2 entry by interfering with Spike protein-mediated membrane fusion
Feng Liu, Chao Shang, Cheng Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 142233-142233
Closed Access
Drug Repurposing Against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
Sarah Aherfi, Bruno Pradines, Christian Devaux, et al.
Future Microbiology (2021) Vol. 16, Iss. 17, pp. 1341-1370
Open Access | Times Cited: 34
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, et al.
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 6, pp. 435-449
Open Access | Times Cited: 32
Autophagy‐linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS‐CoV‐2 entry into human cells
Alejandro P. Ugalde, Gabriel Bretones, David Rodrı́guez, et al.
The EMBO Journal (2022) Vol. 41, Iss. 21
Open Access | Times Cited: 26
SARS-CoV-2 remodels the Golgi apparatus to facilitate viral assembly and secretion
Jianchao Zhang, Andrew A. Kennedy, Daniel Macedo de Melo Jorge, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
Evaluation of Broad Anti-Coronavirus Activity of Autophagy-Related Compounds Using Human Airway Organoids
Rina Hashimoto, Tomokazu Tamura, Yukio Watanabe, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 4, pp. 2276-2287
Closed Access | Times Cited: 14
Tight junction protein occludin is an internalization factor for SARS-CoV-2 infection and mediates virus cell-to-cell transmission
Jialin Zhang, Wenyu Yang, Sawrab Roy, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 17
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top